Viewing Study NCT03063632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:31 PM
Ignite Modification Date: 2026-02-24 @ 2:07 PM
Study NCT ID: NCT03063632
Status: COMPLETED
Last Update Posted: 2023-10-25
First Post: 2017-02-22
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Myxoid Liposarcoma View
None Metastatic Round Cell Liposarcoma View
None Metastatic Synovial Sarcoma View
None Recurrent Mycosis Fungoides and Sezary Syndrome View
None Refractory Mycosis Fungoides and Sezary Syndrome View
None Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7 View
None Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7 View
None Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7 View
None Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7 View
None Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7 View
None Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7 View
None Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7 View
None Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v7 View
None Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7 View
None Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7 View
None Unresectable Synovial Sarcoma View
Keywords: